Kalshi Targets Biopharma with Prediction Markets for Clinical Trials and FDA Approvals

Prediction markets, long established in sports, politics, and entertainment, are now making their way into the biopharma sector. This innovation aims to apply market-based forecasting to clinical trials and FDA approval outcomes, potentially transforming how drug development risks and timelines are assessed.